2023
Reggiardo G, Lo Giudice M, Lalli S, Rinaldi G, Albanese A.
Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
Front. Neurol., 20 April 2023, Sec. Dementia and Neurodegenerative Diseases, Volume 14 – 202, doi.org/10.3389/fneur.
Giannuzzi V, Ruggieri L, Conte R, Manfredi C, Felisi M, Kubiak C, Matei M, Malik S, Demotes J, Ceci A, Bonifazi D.
PedCRIN tool for the biosamples management in paediatric clinical trials
Clin Transl Sci. 2023 Feb 9. doi: 10.1111/cts.13489. Online ahead of print.
2022
Lederer C.W, Koniali L, Buerki-Thurnherr T, Papasavva P.L, La Grutta S, Licari A, Staud F, Bonifazi D, Kleanthous M.
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies
Pharmaceutics 2022, 14, 793. doi.org/10.3390/pharmaceutics14040793
Sultana J, Crisafulli S, Almas M, Antonazzo I, Baan E, Bartolini C, Bertuccio MP, Bonifazi F, Capuano A, Didio A, Ehrenstein V, Felisi MG, Ferrajolo C, Fontana A, Francisca R, Fourrier-Reglat A, Fortuny J, Gini R, Hyeraci G, Hoeve C, Kontogiorgis C, Isgrò V, Lalagkas PN, L’Abbate L, Layton D, Landi A, Narduzzi S, Roque Pereira L, Poulentzas G, Rafaniello C, Roberto G, Scondotto G, Sportiello L, Toma M, Toussi M, Verhamme K, Volpe E, Trifirò G
Overview of the EU PAS register post-authorization studies performed in Europe from September 2010 to December 2018
Pharmacoepidemiol Drug Saf 2022 Jan 29. doi: 10.1002/pds.5413. Online ahead of print
Caminiti C, Maglietta G, Frau I, Peruzzotti G, Felisi M, van Dijk A and on behalf of AICRO’s Clinical Trial Center Working Group (WG-CTC)
Presence and activities of clinical research coordinators at Italian Health Care Institutions: A national cross-sectional survey
Journal of Clinical and Translational Science 2022 Jan 24; 6:e1, 1–7. doi: 10.1017/cts.2021.872
2021
Sainz T, Pignataro V, Bonifazi D, Ravera S, José Mellado M, Pérez-Martínez A, Escudero A, Ceci A, Calvo C
Human Microbiome in Children, at the Crossroad of Social Determinants of Health and Personalized Medicine
Children (Basel) 2021 Dec; 8(12): 1191. Published online 2021 Dec 16
Giannuzzi V, Felisi M, Bonifazi D, Devlieger H, Papanikolaou G, Ragab L, Fattoum S, Tempesta B, Reggiardo G, Ceci A
Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project
BMC Med Ethics. 2021; 22: 49. Published online 2021 Apr 29. doi: 10.1186/s12910-021-00618-2
Ruggieri L, Ceci A, Bartoloni F, Elie V, Felisi M, Jacqz-Aigrain E, Lupo M, Malik S, Manfredi C, Reggiardo G, Demotes J, Bonifazi D.
Paediatric clinical research in Europe: an insight on experts’ needs and perspectives
Contemporary Clinical Trials Communications 21 (2021) 100735
Lupo M, Akuffo E, Lettieri M, Bonifazi D, Marini S, Dehlinger-Kremer M.
The Current Status of European Research Related to COVID-19: The EUCROF Perspective
2021 MJH Life Sciences and Applied Clinical Trials
Toma M, Felisi M, Bonifazi D, Bonifazi F, Giannuzzi V, Reggiardo G, de Wildt S, Ceci A and TEDDY European Network of Excellence for Paediatric Research.
Paediatric Medicines in Europe: The Paediatric Regulation – Is It Time for Reform?
Front. Med., 02 February 2021 | Vol. 8 https://doi.org/10.3389/
2020
Aurich B, Vermeulen E, Elie V, Driessens MHE, Kubiak C, Bonifazi D, Jacqz-Aigrain E.
Informed consent for neonatal trials: practical points to consider and a check list.
BMJ Paediatrics Open. 29 December 2020; doi.org/10.1136/bmjpo-2020-000847
de Leeuw TG, van der Zanden T, Ravera S, Felisi M, Bonifazi D, Tibboel D, Ceci A, Kaguelidou F, de Wildt SN; GAPP Consortium.
Diagnosis and Treatment of Chronic Neuropathic and Mixed Pain in Children and Adolescents: Results of a Survey Study amongst Practitioners.
Children (Basel) 2020 Nov; 7(11): 208 doi: 10.3390/
Turner MA, Cheng K, de Wildt S, Hildebrand H, Attar S, Rossi P, Bonifazi D, Ceci A, Claverol J, Nafria B, Giaquinto C.
European research networks to facilitate drug research in children.
Br J Clin Pharmacol. 2020 Sep 6. doi: 10.1111/bcp.14545. Online ahead of print.
Maggio A, Kattamis A, Felisi M, Reggiardo G, El-Beshlawy A, Bejaoui M, Sherief L, Christou S, Cosmi C, Della Pasqua O, Del Vecchio GC, Filosa A, Cuccia L, Hassab H, Kreka M, Origa R, Putti MC, Spino M, Telfer P, Tempesta B, Vitrano A, Tsang YC, Zaka A, Tricta F, Bonifazi D, Ceci A.
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.
Lancet Haematol. 2020 Jun;7(6):e469-e478.
2019
Ruggieri L, Bonifazi D, Landi A, Bonifazi F, Bartoloni F, Costello M, Felisi MG, Gasthuys E, Godo A, Martinon Torres F, Nadal D, Nuytinck L, Rocchi F, Turner M, Ceci A.
Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trials.
Acta Paediatr. 2019 Sep 18. doi: 10.1111/apa.15020.
Ceci A, Conte R, Didio A, Bonifazi D, Felisi M, Giannuzzi V, Bonifazi F.
An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload.
Expert Opinion on Orphan Drugs, 2019;7(4):181-197.
Kaguelidou F, Le Roux E, Mangiarini L, Lundin R, de Leeuw TG, Della Pasqua O, Felisi M, Bonifazi D, Tibboel D, Ceci A, de Wildt SN, Alberti C; GAPP consortium.
Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol.
BMJ Open. 2019 Feb 20;9(2):e023296. doi: 10.1136/bmjopen-2018-023296.
Orlando G, Murphy S, Bussolati B, Clancy M, Migliaccio G, Murray P.
Rethinking Regenerative Medicine From a Transplant Perspective (and Vice Versa).
Transplantation. 2019 Feb;103(2):237-249
2018
Ranucci G, Buccigrossi V, Borgia E, Piacentini D, Visentin F, Cantarutti L, Baiardi P, Felisi M, Spagnuolo MI, Zanconato S, Baraldi E, Giaquinto C, Guarino A.
Galacto-Oligosaccharide/Polidextrose Enriched Formula Protects against Respiratory Infections in Infants at High Risk of Atopy: A Randomized Clinical Trial.
Nutrients. 2018 Mar 1;10(3).
Boulkedid R, Abdou AY, Desselas E, Manégat M, de Leeuw TG, Avez-Couturier J, Dugue S, Mareau C, Charron B, Alberti C, Kaguelidou F; GAPP Consortium.
The research gap in chronic paediatric pain: A systematic review of randomised controlled trials.
Eur J Pain. 2018 Feb;22(2):261-271 Review.
Botzenhardt S, Felisi M, Bonifazi D, Del Vecchio GC, Putti MC, Kattamis A, Ceci A, Wong ICK, Neubert A; DEEP consortium (collaborative group).
Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study.
Haematologica. 2018 Jan;103(1): e1-e4.
2017
Giannuzzi V, Landi A, Bosone E, Giannuzzi F, Nicotri S, Torrent-Farnell J, Bonifazi F, Felisi M, Bonifazi D, Ceci A.
Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs.
BMJ Open. 2017 Sep 11;7(9): e017358.
Veal GJ, Malik A, Lupo M, MacFarlane S, Lepola P, Costello M, Ceci A, Boué C, Lecour C, Otto A, Rastegari M, Berry P.
Investigating the roles and training of paediatric research nurses working across Europe: a questionnaire-based survey
BMJ Paediatrics Open 2017;1: e000170.
Bonifazi F, Conte R, Baiardi P, Bonifazi D, Felisi M, Giordano P, Giannuzzi V, Iacono A, Padula R, Pepe A, Caterina Putti M, Ruggieri L, Carlo Del Vecchio G, Filosa A, Maggio A, Ceci A; HTA-THAL Multiregional Registry.
Pattern of complications and burden of disease in patients affected by beta thalassemia major.
Curr Med Res Opin. 2017 Aug;33(8):1525-1533.
A. van Dijk, S. Sacchi on behalf of the Working Group (Donato Bonifazi, Vittorio Carrera, Mariagrazia Felisi, Mariangela Lupo, Stefano Marini e Lisa Parigi, Angela Del Vecchio, Caterina Caminiti, Francesca Diodati, Elisa Iezzi, Giuseppe Maglietta, Barbara Marcomini, Veronica Rossolini, Giovanni Gori, Fulvio Ferrara, Silvano Berioli, Mario Fraticelli, Eleonora Sfreddo, Yvonne Cernò, Antonino Amato, Luca Angerame, Elena Carafelli, Marina Cicerone, Betty Polikar, Margherita Zona, Roberto Poscia, Umberto Filibeck).
White Paper AICRO – Working Group Clinical Trial Centers.
AICRO – Working Group CTC May 15, 2017
Giannuzzi V, Conte R, Landi A, Ottomano SA, Bonifazi D, Baiardi P, Bonifazi F, Ceci A.
Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen.
Orphanet J Rare Dis. 2017 Apr 3;12(1):64.
Bellanti F, Del Vecchio GC, Putti MC, Maggio A, Filosa A, Cosmi C, Mangiarini L, Spino M, Connelly J, Ceci A, Della Pasqua O; Consortium DEferiprone Evaluation in Paediatrics (DEEP).
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.
Br J Clin Pharmacol. 2017 Mar;83(3):593-602.
Giannuzzi V, Devlieger H, Margari L, Odlind VL, Ragab L, Bellettato CM, D’Avanzo F, Lampe C, Cassis L, Cortès-Saladelafont E, Cazorla ÁG, Barić I, Cvitanović-Šojat L, Fumić K, Dali CI, Bartoloni F, Bonifazi F, Scarpa M, Ceci A.
The ethical framework for performing research with rare inherited neurometabolic disease patients.
Eur J Pediatr. 2017 Mar;176(3):395-405. doi: 10.1007/s00431-017-2852-9. Epub 2017 Jan 16. Review.
2016
Murgia A, Veronesi E, Candini O, Caselli A, D’souza N, Rasini V, Giorgini A, Catani F, Iughetti L, Dominici M, Burns JS.
Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?
PLoS One. 2016 Oct 6;11(10):e0163629.
Smania G, Baiardi P, Ceci A, Cella M, Magni P.
Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part II: Bayesian Approaches. CPT.
Pharmacometrics Syst Pharmacol. 2016 Aug;5(8):402-10.
Baldissarro E, Aquilani R, Boschi F, Baiardi P, Iadarola P, Fumagalli M, Pasini E, Verri M, Dossena M, Gambino A, Cammisuli S, Viglio S.
The Hip Functional Retrieval after Elective Surgery May Be Enhanced by Supplemented Essential Amino Acids.
BioMed Research International, vol. 2016, Article ID 9318329, 10 pages, 2016.
Conte R, Ruggieri L, Gambino A, Bartoloni F, Baiardi P, Bonifazi D, Bonifazi F, Felisi M, Giannuzzi V, Padula R, Pepe A, Putti MC, Del Vecchio GC, Maggio A, Filosa A, Iacono A, Mangiarini L, Ceci A.
The Italian multiregional thalassemia registry: Centers characteristics, services, and patients’ population.
Hematology. 2016 Aug;21(7):415-24.
Botzenhardt S, Sing CW, Wong IC, Chan GC, Wong LY, Felisi M, Rascher W, Ceci A, Neubert A.
Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-dependent Thalassaemia.
Curr Drug Saf. 2016;11(2):137-44.
2015
Ruggieri L, Giannuzzi V, Baiardi P, Bonifazi F, Davies EH, Giaquinto C, Bonifazi D, Felisi M, Chiron C, Pressler R, Rabe H, Whitaker MJ, Neubert A, Jacqz-Aigrain E, Eichler I, Turner MA, Ceci A; on behalf of the GRiP Consortium.
Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines.
Eur J Pediatr. 2015 174(4):481-91.
2014
Bonifazi E, Milano A, Gambino A.
Prevention and treatment of hemangioma rebound after discontinuation of propranolol.
Eur. J. Pediat. Dermatol. 2014;(24) 35-43.
Aquilani R, D’Antona G, Baiardi P, Gambino A, Iadarola P, Viglio S, Pasini E, Verri M, Barbieri A, Boschi F.
Essential amino acids and exercise tolerance in elderly muscle-depleted subjects with chronic diseases: a rehabilitation without rehabilitation?
Biomed Res Int. 2014; 2014:341603.
Ceci A, Mangiarini L, Bonifazi F, Conte R, on behalf of the HTA-THAL Multiregional Registry.
Multidisciplinary care in haemoglobinopathies.
Thalassemia Reports. 2014; 4(3)68-74.
Turner MA, Catapano M, Hirschfeld S, Giaquinto C; Global Research in Paediatrics.
Paediatric drug development: the impact of evolving regulations.
Adv Drug Deliv Rev. 2014 Jun;73:2-13.
2012
Mellado Peña MJ, Piñeiro Pérez R, Medina Claros AF, Ceci A.
Use, implementation and impact of the TEDDY network in Europe.
Farm Hosp. 2012 Mar-Apr;36(2):109-10.
Altavilla A, Manfredi C, Baiardi P, Dehlinger-Kremer M, Galletti P, Pozuelo AA, Chaplin J, Ceci A.
Impact of the new european paediatric regulatory framework on ethics committees: overview and perspectives.
Acta Paediatr. 2012 Jan;101(1): e27-32.
2011
Maggio A, Filosa A, Vitrano A, Aloj G, Kattamis A, Ceci A, Fucharoen S, Cianciulli P, Grady RW, Prossomariti L, Porter JB, Iacono A, Cappellini MD, Bonifazi F, Cassarà F, Harmatz P, Wood J, Gluud C.
Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials.
Blood Cells Mol Dis. 2011 Oct 15;47(3):166-75.
Lutsar I, Trafojer UM, Heath PT, Metsvaht T, Standing J, Esposito S, de Cabre VM, Oeser C, Aboulker JP; NeoMero Consortium. Collaborators (12) Giaquinto C, Rossi P, Esposito S, Sharland M, Aboulker J, Heininger U, Lutsar I, Roilides E, Warris A, Usonis V, Terés FO, Ceci A.
Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial.
Trials. 2011 Sep 30;12:215.
Ceci A, Mangiarini L, Felisi M, Bartoloni F, Ciancio A, Capra M, D’Ascola D, Cianciulli P, Filosa A.
The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.
Anemia. 2011; 2011:435683.
Sen EF, Verhamme KM, Felisi M, ‘t Jong GW, Giaquinto C, Picelli G, Ceci A, Sturkenboom MC; TEDDY European Network of Excellence.
Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age.
Br J Clin Pharmacol. 2011 Jun;71(6):943-50.
Baiardi P, Giaquinto C, Girotto S, Manfredi C, Ceci A; on behalf of the TEDDY Network of Excellence.
Innovative study design for paediatric clinical trials.
Eur J Clin Pharmacol. 2011 May;67 Suppl 1:109-15.
Sen EF, Verhamme KM, Neubert A, Hsia Y, Murray M, Felisi M, Giaquinto C, ‘t Jong GW, Picelli G, Baraldi E, Nicolosi A, Ceci A, Wong IC, Sturkenboom MC; on behalf of the TEDDY European Network of Excellence.
Assessment of Pediatric asthma drug use in three European countries; a TEDDY study.
Eur J Pediatr. 2011 Jan;170(1):81-92
2010
Neubert A, Verhamme K, Murray ML, Picelli G, Hsia Y, Sen FE, Giaquinto C, Ceci A, Sturkenboom M, Wong IC; TEDDY Network of Excellence.
The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands.
Pharmacol Res. 2010 Sep;62(3):243-8.
Rocchi F, Paolucci P, Ceci A, Rossi P.
The european paediatric legislation: benefits and perspectives.
Ital J Pediatr. 2010 Aug 17;36:56.
Hsia Y, Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Sen F, Giaquinto C, Ceci A, Wong IC; on behalf of the TEDDY Network of Excellence.
Comparison of antiepileptic drug prescribing in children in three European countries.
Epilepsia. 2010 May;51(5):789-96.
Baiardi P, Ceci A, Felisi M, Cantarutti L, Girotto S, Sturkenboom M, Baraldi E.
In-label and off-label use of respiratory drugs in the Italian paediatric population.
Acta Paediatr. 2010 Apr;99(4):544-9.
2009
Ceci A, Giaquinto C, Aboulker JP, Baiardi P, Bonifazi F, Della Pasqua O, Nicolosi A, Taruscio D, Sturkenboom M, Wong I.
The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence.
Paediatr Drugs. 2009;11(1):18-21.
Papers within the TEDDY monograph (The EU Paediatric Regulation):
- Ceci A.
TEDDY Network of excellence: Monograph on paediatric medicines
Pharmaceuticals Policy and Law, 2009;11(1,2):11-12. - Ceci A, Baiardi P, Bonifazi F, Giaquinto C, Mellado Pena MJ, Mincarone P, Nicolosi A, Sturkenboom M, Wong I.
TEDDY NoE project in the framework of the EU paediatric regulation
Pharmaceuticals Policy and Law, 2009;11(1,2):13-21 - Krekelsa E, Ceci A, Iolascon A, Girotto S, Della Pasqua O.
The role of paediatric pharmacogenetic studies in Europe
Pharmaceuticals Policy and Law, 2009;11(1,2):23-30 - Felisi M, Padula R, Bartoloni F, Grosch-Worner I, Kagedal B, Mellado Pena MJ, Parry J, Stuchlik A, Verhamme K, Ceci A.
TEDDY EPMD: A European paediatric medicines database
Pharmaceuticals Policy and Law, 2009;11(1,2):31-39 - Neubert A, Felisi M, Bonifazi A, Manfredi C, Wong ICK, Ceci A.
Off-label and unlicensed use of medicines for children
Pharmaceuticals Policy and Law, 2009;11(1,2):41-49 - Sturkenboom M, Felisi M, Manfredi C, Neubert A, Cantarutti L, Padula R, Sen F, Verhamme K.
Paediatric status and off-label use of drugs in children in Italy, United Kingdom and the Netherlands
Pharmaceuticals Policy and Law, 2009;11(1,2):51-59 - Catapano M, Manfredi C, Paolucci P, Cross H, Verhamme K, Mellado Pena MJ, Grosch-Worner I, Knibbe C, Ceci A.
Recommendation for drug development for children
Pharmaceuticals Policy and Law, 2009;11(1,2):61-70 - Baiardi P, Girotto S, Della Pasqua O, Harper L, Grosch-Worner I, Ceci A, Giaquinto C.
Clinical trials for paediatric medicines in Europe
Pharmaceuticals Policy and Law, 2009;11(1,2):71-78 - Altavilla A, Giaquinto C, Giocanti D, Manfredi C, Aboulker JP, Bartoloni F, Cattani E, Lo Giudice M, Mellado Pena MJ, Nagler R, Peterson C, Vajnerova O, Bonifazi F, Ceci A.
Activity of ethics committees in Europe on issues related to clinical trials in paediatrics: Results of a survey
Pharmaceuticals Policy and Law, 2009;11(1,2):79-87 - Verhamme K, Bonifazi F, Ceci A, Elferink-Stinkens P, Murray M, Neubert A, Nicolosi A, Stricker B, Wong I, Sturkenboom M.
Adverse drug reactions reporting in children
Pharmaceuticals Policy and Law, 2009;11(1,2):89-98 - Trama A, Pierannunzio D, Loizzo A, Domenica Taruscio D, Ceci A.
Availability of medicines for rare diseases in EU countries
Pharmaceuticals Policy and Law, 2009;11(1,2):101-109
2008
Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC; TEDDY Network of Excellence.
Databases for pediatric medicine research in Europe–assessment and critical appraisal.
Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1155-67.
Neubert A, Wong IC, Bonifazi A, Catapano M, Felisi M, Baiardi P, Giaquinto C, Knibbe CA, Sturkenboom MC, Ghaleb MA, Ceci A.
Defining off-label and unlicensed use of medicines for children: Results of a Delphi survey.
Pharmacol Res. 2008 Nov-Dec;58(5-6):316-22.
Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R, Ronchi A, Saluzzo CM, Azzaretti A, Rodolico G, Montagna M, Amatu A, Teragni C, Palumbo I, Traverso E, Tonini S, Villani L, Scelsi M, Baiardi P, Felisi MG, Sottotetti F, Tagliaferri B, Riccardi A.
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
Anticancer Res. 2008 Nov-Dec;28(6B):3835-42.
Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC; TEDDY European Network of Excellence.
Drug use in children: cohort study in three European countries.
BMJ. 2008 Nov 24;337:a2245.
Altavilla A, Giaquinto C, Ceci A.
European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
J Int Bioethique. 2008 Sep;19(3):17-48, 121-2.
Paolucci P, Jones KP, del Carmen Cano Garcinuno M, Catapano M, Iolascon A, Ceci A.
Challenges in prescribing drugs for children with cancer.
Lancet Oncol. 2008 Feb;9(2):176-83.
2007
Krekels EH, van den Anker JN, Baiardi P, Cella M, Cheng KY, Gibb DM, Green H, Iolascon A, Jacqz-Aigrain EM, Knibbe CA, Santen GW, van Schaik RH, Tibboel D, Della Pasqua OE.
Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations.
Expert Opin Pharmacother. 2007 Aug;8(12):1787-99.
Sturkenboom M, Fatma E, Verhamme K, Herings R, Neubert A, Felisi M, Ceci A.
The Teddy Network: epidemiological trends in paediatric drug use in Europe.
EJHP Practice 2007; 13(6):22-24.
2006
Ceci A, Felisi M, Baiardi P, Bonifazi F, Catapano M, Giaquinto C, Nicolosi A, Sturkenboom M, Neubert A, Wong I.
Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years
Eur J Clin Pharmacol 2006. Nov;62(11):947-52.
Ceci A, Baiardi P, Catapano M, Felisi M, Cianciulli P, De Sanctis V, Del Vecchio GC, Magnano C, Meo A, Maggio A.
Risk factors for death in patients with beta-thalassemia major: results of a case-control study.
Haematologica. 2006 Oct;91(10):1420-1.
Ceci A, Giannino ML.
La farmacocinetica in pediatria: uno strumento importante per un giusto approccio terapeutico.
Area Pediatrica 2006; 8:39-44.
Ceci A.
Un nuovo Regolamento Europeo per le Medicine Pediatriche.
Occhio Clinico Pediatria, 2006; 1:2-3.
2005
Ceci A.
Legislazione e criticità nella sperimentazione dei farmaci.
Monitor, 2005; 12(IV):67-71.
Ceci A.
Esigenze di sperimentazione clinica di psicofarmaci per uso pediatrico.
Prospettive in Pediatria 2005; 35:221-229.
2004
Ceci A.
Significato e ruolo della farmacovigilanza in età pediatrica.
Occhio Clinico Pediatria, 2004; 9:264-269.
Ceci A, Baiardi P, Ravera S, Chiò E, Pellegri C, Negrini C, Capitelli G, Cela R, Corda G, Gaia E, Gozzi S, Marocchino F, Marrazzo E, Pizzini A, Ravaglia A, Sullo F, Tonini M.
Impiego degli Inibitori della Pompa Protonica (IPP) in Piemonte: indagine sulle abitudini prescrittive dei Medici di medicina Generale.
Farmeconomia e percorsi terapeutici 2004; 5(2):39-51.
2003
Ceci A, Felisi M, De Sanctis V, De Mattia D.
Pharmacotherapy of iron overload in thalassaemic patients.
Expert Opin Pharmacother. 2003 Oct;4(10):1763-74.
2002
Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S,Reggio S, Rondini G.
Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Eur J Clin Pharmacol. 2002 Nov;58(8):495-500.
Cipollina L, Folino-Gallo P, Grande D, Felisi M, Ravera S, Ceci A.
Mutua disponibilità, prezzi e rimborsabilità di farmaci autorizzati con procedura centralizzata europea.
Farmacoeconomia e percorsi terapeutici, 2002; 3(1): 15-27.
Ceci A, Baiardi P, Felisi M, Cappellini MD, Carnelli V, De Sanctis V, Galanello R, Maggio A, Masera G, Piga A, Schettini F, Stefano I, Tricta F.
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients.
Br J Haematol. 2002 Jul;118(1):330-6.
Baiardi P, Felisi M, Cipollina L, Lerro G, Carnelli V, Rondini G, Ceci A.
Availability of paediatric medicines in Italy.
Quaderni di Pediatria, 2002:1(3):203-206
2001
Ceci A., Felisi M., Ravera S.
Farmacovigilanza in Pediatria.
Rubrica Mensile di Area Pediatrica, 2001-2008.